QIX Deutschland
16.789,69
PKT
+73,80
PKT
+0,44
%
Werbung
Analysen zu QIX Deutschland-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.02.25 | Siemens Healthineers Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | Evonik Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | RATIONAL Outperform | Bernstein Research | |
| 06.02.25 | Hannover Rück Buy | Jefferies & Company Inc. | |
| 06.02.25 | Hannover Rück Kaufen | DZ BANK | |
| 06.02.25 | Hannover Rück Outperform | RBC Capital Markets | |
| 06.02.25 | Bechtle Buy | Deutsche Bank AG | |
| 06.02.25 | Bechtle Kaufen | DZ BANK | |
| 06.02.25 | RATIONAL Reduce | Baader Bank | |
| 06.02.25 | Sartorius vz. Sector Perform | RBC Capital Markets | |
| 06.02.25 | RATIONAL Underperform | RBC Capital Markets | |
| 06.02.25 | RATIONAL Hold | Warburg Research | |
| 06.02.25 | Siemens Healthineers Buy | Jefferies & Company Inc. | |
| 06.02.25 | Hannover Rück Neutral | UBS AG | |
| 06.02.25 | Siemens Healthineers Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | Hannover Rück Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Siemens Healthineers Outperform | Bernstein Research | |
| 06.02.25 | Siemens Healthineers Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Bechtle Buy | Baader Bank | |
| 05.02.25 | Bechtle Buy | Jefferies & Company Inc. | |
| 05.02.25 | Bechtle Neutral | UBS AG | |
| 05.02.25 | Henkel vz. Market-Perform | Bernstein Research | |
| 04.02.25 | Brenntag Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.25 | SAP Add | Baader Bank | |
| 04.02.25 | Fresenius Medical Care (FMC) St. Hold | Warburg Research | |
| 04.02.25 | Symrise Neutral | Goldman Sachs Group Inc. | |
| 04.02.25 | Brenntag Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | Henkel vz. Neutral | UBS AG | |
| 03.02.25 | adidas Buy | UBS AG | |
| 03.02.25 | Knorr-Bremse Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.02.25 | Knorr-Bremse Buy | Jefferies & Company Inc. | |
| 31.01.25 | Symrise Kaufen | DZ BANK | |
| 31.01.25 | Symrise Add | Baader Bank | |
| 31.01.25 | Symrise Hold | Jefferies & Company Inc. | |
| 31.01.25 | Symrise Buy | Deutsche Bank AG | |
| 31.01.25 | Carl Zeiss Meditec Neutral | UBS AG | |
| 31.01.25 | Fresenius Medical Care (FMC) St. Neutral | UBS AG | |
| 31.01.25 | Siemens Healthineers Neutral | UBS AG | |
| 31.01.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Merck Buy | Deutsche Bank AG |